Human antibodies derived from immunized xenomice
CA 2219361 C · Owner: Abgenix, Inc. · Inventors: Jakobovits, Aya; Brenner, Daniel G.; Kucherlapati, Raju
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Fully human antibodies against a specific antigen can be prepared by administering the antigen to a transgenic animal which has been modified to produce such antibodies in response to antigenic challenge but whose , endogenous loci have been disabled. Various subsequent manipulations can be performed to obtain either antibodies per se or analogs thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 29, 1996 and granted February 28, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 29, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 29, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.